Vaxxa delivered strong Q2 2024 results with doubled revenue, positive EBITDA, and net income, supported by robust growth in its self-service auction platform and a solid cash position. Major platform upgrades and geographic expansion are planned for H2 2024.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.